Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
Endocrine Connections|April 8, 2025
Estimation of kidney function in Graves' disease using creatinine and cystatin CSorena Abbaszadeh, Martin H Lundqvist, Östen Ljunggren, et al.Journal of the American Chemical Society|May 14, 2008
Fluorescence blinking, exciton dynamics, and energy transfer domains in single conjugated polymer chainsHongzhen Lin, Seyed R Tabaei, Daniel Thomsson, et al.Frontiers in Integrative Neuroscience|September 20, 2023
Pupil light reflex dynamics in Parkinson's diseasePanagiota Tsitsi, Mattias Nilsson, Josefine Waldthaler, et al.Clinical Neurology and Neurosurgery|May 19, 2026
Biomarkers of plasticity and recovery after stroke: Insights from the PRACTISE trialMia Kolmos, Nina Vindegaard Sørensen, Karen Lind Gandrup, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 5, 2004
Polyelectrolyte complexes as a tool for purification of plasmid DNA. Background and developmentPer-Olof Wahlund, Per-Erik Gustavsson, Vladimir A Izumrudov, et al.Journal of Molecular Neuroscience : MN|May 11, 2018
Co-expression of β Subunits with the Voltage-Gated Sodium Channel NaV1.7: the Importance of Subunit Association and Phosphorylation and Their Effects on Channel Pharmacology and BiophysicsMaxim V Sokolov, Petra Henrich-Noack, Carina Raynoschek, et al.BMC Nephrology|April 28, 2025
Potassium binders in clinical practice: understanding potassium binder use in contemporary Swedish healthcare-the DEMONSTRATE databaseHans Furuland, Anders Olof Larsson, Per Bjellerup, et al.Journal of Palliative Care|July 26, 2014
Experience of guilt and strategies for coping with guilt in patients with severe COPD: a qualitative interview studySusann Strang, Mary Farrell, Lars-Olof Larsson, et al.SLAS Technology|May 1, 2026
Reverse transcriptase mediated signal amplification in ligand binding assaysVeronika Nordal, Johanna Hedin, Jessica Pettersson, et al.Journal of Internal Medicine|March 26, 2026
Potassium binders and continuation of renin-angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure (the DEMONSTRATE database)Hans Furuland, Anders Olof Larsson, Milica Uhde, et al.Pageof 7